Johanna Hynninen
 Adjunct professor, MD, Gynecologic oncologist

  

  

  

9 of 10

  

  

  

---

• Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer  (2018)  
  • Cancer Research
   Emilia Kozłowska, Anniina Färkkilä, Tuulia Vallius, Olli Carpén, Jukka Kemppainen, Seija Grénman, Rainer Lehtonen, Johanna Hynninen, Sakari Hietanen, Sampsa Hautaniemi

  
  

• Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells  (2017)  
  • Molecular and Cellular Proteomics
   Nguyen Elizabeth V, Huhtinen Kaisa, Goo Young Ah, Kaipio Katja, Andersson Noora, Rantanen Ville, Hynninen Johanna, Lahesmaa Riitta, Carpen Olli, Goodlett David R

  
  

• Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer  (2017)  
  • Tumor Biology
   Vallius T, Hynninen J, Auranen A, Matomaki J, Oksa S, Roering P, Grenman S

  
  

• Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Mullerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors  (2017)  
  • Gynecologic Oncology
   Haltia UM, Hallamaa M, Tapper J, Hynninen J, Alfthan H, Kalra B, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Farkkila A

  
  

• Uusi lektiini-avusteinen määrityskonsepti parantamaan CA-125-kasvainmerkkiaineen munasarjasyöpäspesifisyyttä  (2017)  
  • Kliin lab
   Kekki H, Gidwani K, Huhtinen K, Hynninen J, Pettersson K

  
  

• (18)F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer  (2016)  
  • Gynecologic Oncology
   Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J

  
  

• A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources  (2016)  
  • Clinical Chemistry
   Gidwani Kamlesh, Huhtinen Kaisa, Kekki Henna, van Vliet Sandra, Hynninen Johanna, Koivuviita Niina, Perheentupa Antti, Poutanen Matti, Auranen Annika, Grenman Seija, Lamminmaki Urpo, Carpen Olli, van Kooyk Yvette, Pettersson Kim

  
  

• Characterization of ascites and tumor-derived ovarian cancer stem-like cells  (2016)  
  • Clinical Cancer Research
   Kaipio K, Chen P, Huhtinen K, Mikkonen P, Ostling P, Mpindi JP, Lehtinen L, Roering P, Korpela T, Wennerberg K, Yadav B, Aittokallio T, Kulesskiy E, Hynninen J, Auranen A, Grenman S, Hautaniemi S, Carpen O

  
  

• REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker  (2016)  
  • PLoS ONE
   Laura Lehtinen, Pia Vesterkvist, Pia Roering, Taina Korpela, Liisa Hattara, Katja Kaipio, John-Patrick Mpindi, Johanna Hynninen, Annika Auranen, Ben Davidson, Caj Haglund, Kristiina Iljin, Seija Grenman, Harri Siitari, Olli Carpen

  
  

• Total metabolic tumor volume change during neoadjuvant chemotherapy in 18f-fdg-pet/ct predicts outcome in advanced epithelial ovarian cancer  (2016)  
  • International Journal of Gynecological Cancer
   Vallius T, Hynninen J, Kemppainen J, Alves V, Oksa S, Matomaki J, Auranen A, Grenman S, Seppanen M